Paradigm Biopharmaceuticals receives European regulatory and ethics approvals for osteoarthritis ...

Nanollose secures United States patent for sustainable fibre technology

BluGlass secures $10.2 million through placement to institutional and sophisticated investors

Genex Power achieves key milestone in construction of Bouldercombe Battery Project in Queensland

Race Oncology set to begin observational stage of phase 1/2b clinical trial for cancer drug

RemSense Technologies awarded $2 million contract from AGC Industries

Emyria enters collaboration partnership with The Pax Centre to develop MDMA-assisted therapy model

Sims seeks to sell 50% interest in LMS Energy

PYC Therapeutics granted clearance by US FDA to commence human trials for new drug candidate

Cash Converters inks agreement to acquire major UK franchise